Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 6Glioma 5Glioblastoma 3Astrocytoma 3Oligodendroglioma 2Keratosis, Actinic 2Skull Base Neoplasms 1Sarcoma 1Precancerous Conditions 1Pituitary Neoplasms 1Oropharyngeal Neoplasms 1Neurofibromatoses 1Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Meningioma 1Leukoplakia, Oral 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Carcinoma, Basal Cell 1

Interventions

talimogene laherparepvec 1diphenylcyclopropenone 1Sirolimus 1Percutaneous Collagen Induction 1Magnetic Resonance Spectroscopy 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neurofibromatoses × Aminolevulinic Acid × Clear all
NCT01682811 2021-06-18

Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)

Medical College of Wisconsin

Phase 1 Completed
20 enrolled 11 charts
CNS

Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡